Abstract
IT is well known that Epstein–Barr virus (EBV) transforms human lymphocytes in vitro, and lymphoblastoid cell lines are established1. Macrophages enhance transformation by EBV in vitro2 but may not be essential3. Inhibition of transformation by EBV in vitro has also been reported, and was first observed when lymphocytes from an adult donor with antibody to EBV were infected with EBV and co-cultivated with autochthonous fibroblasts derived from skin4. Fibroblasts of foetal origin did not have this inhibitory effect. Further studies established the principle that co-cultivation of EBV-infected lymphocytes with autochthonous or allogeneic fibroblasts of adult but not foetal origin, was associated with inhibition of transformation by EBV (ref. 5). This report presents evidence that this type of inhibition of transformation by EBV is specifically mediated by mononuclear cell preparations from donors previously infected with EBV. An immunological basis is highly probable.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Henle, W., Diehl, V., Kohn, G., zur Hausen, H. & Henle, G. Science 157, 1064–1065 (1967),
Pope, J. H., Scott, W. & Moss, D. J. Nature new Biol. 246, 140–141 (1973),
Schneider, U. & zur Hausen, H. Int. J. Cancer 15, 59–66 (1975).
Pope, J. H., Scott, W. & Moss, D. J. Int. J. Cancer 14, 122–129 (1974).
Moss, D. J., Pope, J. H. & Scott, W. Med. Microbiol. Immun. 162, 159–167 (1976).
Pope, J. H. in Oncogenesis and Herpesviruses II, IARC Scientific Publications No. 11, Part 1 (ed. de-Thé, G., Epstein, M. A. & zur Hausen, H.) 367–378 (IARC, Lyon, 1975).
Moss, D. J. & Pope, J. H. Int. J. Cancer 15, 503–511 (1975).
Svedmyr, E. & Jondal, M. Proc. natn. Acad. Sci. U.S.A, 72, 1622–1626 (1975),
Rickinson, A. B., Crawford, D. & Epstein, M. A., Clin. exp. Immun. 28, 72–79 (1977).
Takasugi, M., Mickey, M. R. & Terasaki, P. I. Cancer Res. 33, 2898–2902 (1973).
Hutt, L. M., Huang, Y. T., Dascomb, H. E. & Pagano, J. S. J. Immun. 115, 243–248 (1975).
Jondal, M. & Pross, H., Int. J. Cancer 15, 596–605 (1975).
Henle, W. & Henle, G. in Oncogenesis and Herpesviruses II, IARC Scientific Publications No. 11, Part 2 (ed. de-Thé, G., Epstein, M. A. & zur Hausen, H.) 215–224 (IARC, Lyon, 1975).
Epstein, M. A. in Oncogenesis and Herpesviruses II, IARC Scientific Publications No. 11, Part 2 (ed. de-Thé G., Epstein, M. A. & zur Hausen, H.) 141–151 (IARC, Lyon, 1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moss, D., SCOTT, W. & POPE, J. An immunological basis for inhibition of transformation of human lymphocytes by EB virus. Nature 268, 735–736 (1977). https://doi.org/10.1038/268735a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/268735a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.